top of page

Search


The Hard Questions We Don’t Talk About Enough 💬
❤️🩹 A patient’s perspective from someone who lived early feasibility When you’re one of the first people to receive a new heart valve, you learn pretty quickly that innovation is both a miracle and an evolving standard of care. I was an early feasibility EVOQUE patient — part of the group whose outcomes helped shape future FDA approval. The valve saved my life. But being in that first wave also meant stepping into a space where long-term answers were still being written. Th
15 hours ago3 min read


Becoming the Long-Term Data: 5 Years After My EVOQUE Tricuspid Valve (TTVR) and What Comes Next
January 2026 marks the start of my fifth year living with the EVOQUE tricuspid valve, which I received through the TRISCEND II...
Oct 233 min read


From Forgotten to Front Page: CMS Approves National Coverage for Tricuspid Valve Replacement
There was a time—not that long ago—when the tricuspid valve was known as the forgotten valve . If you had severe tricuspid regurgitation...
Apr 31 min read
"If no one else was telling their story, then maybe I needed to tell mine. And maybe, just maybe, that would give others permission to share theirs too."
bottom of page